ANLOTINIB
Clinical trials for ANLOTINIB explained in plain language.
Never miss a new study
Get alerted when new ANLOTINIB trials appear
Sign up with your email to follow new studies for ANLOTINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to shrink lung tumors before surgery
Disease control Recruiting nowThis phase 2 trial tests a combination of three drugs (tislelizumab, anlotinib, and nab-paclitaxel) given before surgery to people with stage III non-small cell lung cancer. The goal is to see if this approach can eliminate or greatly reduce the tumor before it is removed. The st…
Matched conditions: ANLOTINIB
Phase: PHASE2 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a drug cocktail shrink sarcomas before surgery?
Disease control Recruiting nowThis phase 2 trial tests whether giving a drug called anlotinib (which cuts off tumor blood supply) along with immunotherapy (penpulimab) and radiation before surgery can improve outcomes for people with soft tissue sarcoma in the arms, legs, or trunk. The study will enroll 30 ad…
Matched conditions: ANLOTINIB
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC